subglutinol B: an osteogenic agent isolated from Fusarium subglutinans; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 54691259 |
| CHEMBL ID | 480488 |
| MeSH ID | M0549481 |
| Synonym |
|---|
| subglutinol b |
| CHEMBL480488 |
| Assay ID | Title | Year | Journal | Article |
|---|---|---|---|---|
| AID1224292 | Immunosuppressive activity in C57Bl/6 mouse lymphocytes assessed as inhibition of cell proliferation co-incubated with BALB/c mouse stimulator lymphocytes after 72 hrs by [3H]-thymidine incorporation assay | 2014 | ACS medicinal chemistry letters, May-08, Volume: 5, Issue:5 | Biological evaluation of subglutinol a as a novel immunosuppressive agent for inflammation intervention. |
| AID399577 | Immunosuppressive activity in lymphocytes by mixed lymphocyte reaction assay | 2004 | Journal of natural products, Feb, Volume: 67, Issue:2 | Natural products from endophytic microorganisms. |
| AID399578 | Immunosuppressive activity in thymocytes by thymocyte proliferation assay | 2004 | Journal of natural products, Feb, Volume: 67, Issue:2 | Natural products from endophytic microorganisms. |
| AID1224293 | Immunosuppressive activity in mouse thymocytes assessed as inhibition of IL-1-induced cell proliferation for 72 hrs by [3H]thymidine incorporation assay | 2014 | ACS medicinal chemistry letters, May-08, Volume: 5, Issue:5 | Biological evaluation of subglutinol a as a novel immunosuppressive agent for inflammation intervention. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||||
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.51) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 1 (14.29%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 6 (85.71%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||